• Health Economic Research Institute, School of Pharmaceutical Sciences, SunYat-sen University, Guangzhou 510006, P. R. China;
XUAN Jianwei, Email: xuanjw3@mail.sysu.edu.cn
Export PDF Favorites Scan Get Citation

Objective To compare the effectiveness of haemocoagulase agkistrodon and tranexamic acid and sodium chloride in the prevention and treatment of perioperative bleeding in a real world setting. Methods A research database was constructed based on the records of inpatient visits using haemocoagulase agkistrodon and tranexamic acid and sodium chloride according to the SuValue® database from January 1, 2016 to December 31, 2020. The patients were divided into two groups according to the different interventions. After matching with a 1∶1 propensity score, the effectiveness of two groups was compared. Results A total of 858 patients were included in each of the two groups, and there was no statistically significant difference in baseline characteristics between the two groups (P>0.05). Research results showed that patients using haemocoagulase agkistrodon had significantly reduced length of hospital stay, decrease in hematocrit, average estimated surgical bleeding, and decrease in hemoglobin (P<0.01). Conclusion Haemocoagulase agkistrodon has better effectiveness than tranexamic acid and sodium chloride for reducing perioperative blood loss based on current real world evidence.

Citation: LV Jinjin, XUAN Jianwei. Effectiveness of haemocoagulase agkistrodon versus tranexamic acid and sodium chloride in the prevention and treatment of perioperative bleeding: a real-world study. Chinese Journal of Evidence-Based Medicine, 2023, 23(5): 513-516. doi: 10.7507/1672-2531.202209102 Copy

  • Previous Article

    The "carryover effects" mixed-effects model for syndrome differentiation treatment on bronchiectasis: a series of N-of-1 trials
  • Next Article

    Effect of airway pressure release ventilation on the hospital mortality of patients with acute respiratory distress syndrome: a cumulative meta-analysis